Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Antiplatelet factor 4/heparin antibodies in patients with gram negative bacteremia.

Pongas G, Dasgupta SK, Thiagarajan P.

Thromb Res. 2013 Aug;132(2):217-20. doi: 10.1016/j.thromres.2013.06.013. Epub 2013 Jul 4.

PMID:
23830968
[PubMed - indexed for MEDLINE]
2.

Further characterization of antibody and antigen in heparin-induced thrombocytopenia.

Newman PM, Chong BH.

Br J Haematol. 1999 Nov;107(2):303-9.

PMID:
10583216
[PubMed - indexed for MEDLINE]
3.

Heparin-dependent and -independent anti-platelet factor 4 autoantibodies in patients with systemic lupus erythematosus.

Satoh T, Tanaka Y, Okazaki Y, Kaburaki J, Ikeda Y, Kuwana M.

Rheumatology (Oxford). 2012 Sep;51(9):1721-8. doi: 10.1093/rheumatology/kes145. Epub 2012 Jun 19.

PMID:
22718864
[PubMed - indexed for MEDLINE]
4.

Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia.

Alberio L, Kimmerle S, Baumann A, Taleghani BM, Biasiutti FD, Lämmle B.

Am J Med. 2003 May;114(7):528-36.

PMID:
12753876
[PubMed - indexed for MEDLINE]
5.

A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.

Demma LJ, Winkler AM, Levy JH.

Anesth Analg. 2011 Oct;113(4):697-702. doi: 10.1213/ANE.0b013e3182297031. Epub 2011 Jul 25.

PMID:
21788317
[PubMed - indexed for MEDLINE]
6.

Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.

Greinacher A, Gopinadhan M, Günther JU, Omer-Adam MA, Strobel U, Warkentin TE, Papastavrou G, Weitschies W, Helm CA.

Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2386-93. Epub 2006 Jul 27.

PMID:
16873726
[PubMed - indexed for MEDLINE]
Free Article
7.

Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.

Amiral J, Bridey F, Wolf M, Boyer-Neumann C, Fressinaud E, Vissac AM, Peynaud-Debayle E, Dreyfus M, Meyer D.

Thromb Haemost. 1995 Jan;73(1):21-8.

PMID:
7740492
[PubMed - indexed for MEDLINE]
8.

Heparin-platelet factor 4 antibodies in intensive care patients: an observational seroprevalence study.

Levine RL, Hergenroeder GW, Francis JL, Miller CC, Hursting MJ.

J Thromb Thrombolysis. 2010 Aug;30(2):142-8. doi: 10.1007/s11239-009-0425-0.

PMID:
19911252
[PubMed - indexed for MEDLINE]
9.

Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium.

Pouplard C, Amiral J, Borg JY, Vissac AM, Delahousse B, Gruel Y.

Br J Haematol. 1997 Nov;99(2):273-80.

PMID:
9375738
[PubMed - indexed for MEDLINE]
10.

Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4/heparin-like epitopes.

Krauel K, Weber C, Brandt S, Zähringer U, Mamat U, Greinacher A, Hammerschmidt S.

Blood. 2012 Oct 18;120(16):3345-52. doi: 10.1182/blood-2012-06-434985. Epub 2012 Aug 31.

PMID:
22942185
[PubMed - indexed for MEDLINE]
Free Article
11.

Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen.

Greinacher A, Pötzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C.

Thromb Haemost. 1994 Feb;71(2):247-51.

PMID:
8191407
[PubMed - indexed for MEDLINE]
12.
13.

The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia.

Gerotziafas GT, Elalamy I, Lecrubier C, Lebrazi J, Mirshahi M, Potevin F, Lecompte T, Samama MM.

Blood Coagul Fibrinolysis. 2001 Oct;12(7):511-20.

PMID:
11685038
[PubMed - indexed for MEDLINE]
14.

Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.

Prechel MM, Jeske WP, Walenga JM.

Thromb Res. 2010 Apr;125(4):e143-8. doi: 10.1016/j.thromres.2009.10.021.

PMID:
19931120
[PubMed - indexed for MEDLINE]
16.

IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support.

Schenk S, El-Banayosy A, Morshuis M, Arusoglu L, Eichler P, Lubenow N, Tenderich G, Koerfer R, Greinacher A, Prohaska W.

J Thromb Haemost. 2007 Feb;5(2):235-41. Epub 2006 Oct 31.

PMID:
17083649
[PubMed - indexed for MEDLINE]
17.

Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.

Legnani C, Cini M, Pili C, Boggian O, Frascaro M, Palareti G.

Thromb Haemost. 2010 Aug;104(2):402-9. doi: 10.1160/TH10-01-0002. Epub 2010 Jun 10.

PMID:
20539902
[PubMed - indexed for MEDLINE]
18.

Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia.

Whitlatch NL, Kong DF, Metjian AD, Arepally GM, Ortel TL.

Blood. 2010 Sep 9;116(10):1761-6. doi: 10.1182/blood-2010-01-262659. Epub 2010 May 27.

PMID:
20508160
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.

Reilly MP, Taylor SM, Franklin C, Sachais BS, Cines DB, Williams KJ, McKenzie SE.

J Thromb Haemost. 2006 Dec;4(12):2687-94. Epub 2006 Sep 8.

PMID:
16961586
[PubMed - indexed for MEDLINE]
20.

Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis.

Warkentin TE, Sheppard JI, Sun JC, Jung H, Eikelboom JW.

J Thromb Haemost. 2013 Feb;11(2):253-60. doi: 10.1111/jth.12098.

PMID:
23216710
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk